Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you feel like you're barely eating on Mounjaro, or you're worried that hunger has vanished so completely you're not eating enough, you're not imagining it — and you're not alone. Tirzepatide works by signalling fullness through two separate gut-hormone pathways, which can suppress appetite far more powerfully than most people expect. That suppression is the point, but taken too far it can tip into undereating, which creates its own problems. As a prescription-only medicine, tirzepatide is reviewed and dosed by a GPhC-registered prescriber; if your eating has dropped dramatically, that conversation matters.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common misreading of tirzepatide's appetite effect is that if you're not hungry, you don't need to eat. That logic feels intuitive. It's also wrong in a way that can undermine your results. Your body still has a baseline requirement for protein, micronutrients and enough calories to preserve lean muscle, and tirzepatide does nothing to reduce those requirements. What it does reduce, sometimes dramatically, is the signal that reminds you to meet them.
Feeling like you're starving is usually not what's happening physiologically. More often, people describe a version of the opposite: an almost eerie absence of hunger, combined with fullness after just a few bites. The sensation of "starving" tends to arise when very low intake over several days starts producing dizziness, fatigue, irritability or the nausea that paradoxically worsens on an empty stomach. The medicine hasn't made you starve. It's made you forget to eat enough, and the symptoms have caught up. Understanding that distinction changes what you actually need to do about it.
The NHS tirzepatide patient information page notes that nausea is among the most common side effects, and nausea on an empty stomach is typically worse than nausea after a small, plain meal. Eating something, even when you don't feel like it, is part of managing the medicine well.
There's no universal threshold, because bodies differ. But as a practical guide: if you are regularly going more than 24 hours without meaningful food, eating fewer than 800 calories most days, or struggling to manage a quarter of a normal portion, a prescriber needs to know. These aren't arbitrary lines, they are points at which muscle catabolism accelerates, micronutrient deficiencies become more likely, and the medicine's benefit-to-cost balance shifts.
Prescribers have a straightforward set of levers here. A titration pause (staying at the current dose longer before moving up) is one of the most common responses. A dose reduction is another. Neither represents failure; both are planned tools within the treatment protocol. People who are interested in how the dosing schedule is designed, and why the starting strength is what it is, will find the detail in our guide to how to start Mounjaro, including what those first doses are intended to achieve.
Worth noting: the appetite suppression often softens after a few weeks at any given dose as the body adjusts. What feels extreme at week two of a new dose is usually more manageable by week five. That pattern is worth knowing before making changes.
When volume goes down, quality has to go up. Protein is the first priority: it preserves muscle mass, supports satiety signals, and is harder to recover than fat once lost. Aim to include a protein source at every small meal, even if the meal itself is modest. Eggs, Greek yoghurt, fish, legumes and poultry are practical choices that require little preparation and sit well with a suppressed appetite.
Hydration is the second priority, and frequently the most neglected. Tirzepatide slows gastric emptying, which can reduce thirst cues along with hunger cues. Sipping water, diluted squash or broth across the day (rather than waiting to feel thirsty) makes a material difference to how the medicine feels day to day.
Strength-based activity, even light resistance work, helps preserve muscle while in a calorie deficit. It does not need to be strenuous. A walk with a weighted bag, resistance bands, bodyweight movements, all count. These lifestyle foundations complement the treatment rather than fight it, and they're part of what the NHS Live Well guidance on healthy weight describes as the active component of any weight-management approach.
If you'd like to understand more about how the treatment fits into a broader weight-management plan, the weight-loss treatment overview covers the landscape clearly. And for a fuller look at what tirzepatide is and how it works mechanically, the tirzepatide overview page goes deeper on the dual-receptor science.
Some symptoms during Mounjaro treatment need attention promptly rather than managed at home. Severe or persistent stomach pain that spreads towards the back, significant dehydration from repeated vomiting or diarrhoea, or signs of a serious allergic reaction are all reasons to seek medical help the same day, call NHS 111 or your GP. The MHRA's reporting tool at Yellow Card is also there for suspected side effects you want flagged beyond your own care team.
For the more common situation (appetite that has gone so flat that eating is genuinely difficult) the right conversation is with your prescriber. At nume, a named prescriber, not software, reads your consultation and any follow-up contact. That clinical review is available throughout your treatment, not just at the beginning. If something has changed in how the medicine is landing, the aftercare team can connect you with a prescriber quickly.
If you haven't started treatment yet and are weighing up whether tirzepatide is right for you, our guide to starting Mounjaro covers the clinical eligibility picture and what the first weeks actually look like, which is useful context before your first consultation. When you're ready to speak to our prescribers, a free consultation is the starting point. There are no subscriptions, no auto-renewals; your repeat orders are clinically re-reviewed each time. Your pen arrives via DPD, tracked, in plain unbranded packaging, nothing on the box to explain what's inside.
On the cost side, private tirzepatide treatment varies by dose and provider. If you're weighing up the financials, our page on the Eli Lilly Mounjaro UK price increase gives honest context on how the market has moved and what that means for private pricing. Some providers also offer a premium tier, and if you've come across references to Mounjaro Gold, that page explains exactly what it includes and how it differs from the standard treatment pathway.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.